The global micro guide catheter market growth is slated to advance at a CAGR of 6.4% through 2034, reaching US$ 8.02 billion. The micro guide catheter market size will reach US$ 4.32 billion by 2024.
Attributes | Key Insights |
---|---|
Estimated Size in 2024 | US$ 4.32 billion |
Projected Value in 2034 | US$ 8.02 billion |
Value-based CAGR from 2024 to 2034 | 6.4% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The growing prevalence of chronic cardiovascular diseases boosted the demand for heart-related surgeries during the historical period. The pandemic outbreak played a vital role in spurring cardiovascular disorders, promoting immediate diagnosis and treatments. Consequently, this demand generator governed the micro guide catheter market growth in this period.
Attributes | Values |
---|---|
Historical CAGR | 6.6% |
Valuation in 2019 | US$ 2.95 billion |
Valuation in 2023 | US$ 4.06 billion |
Government funding for minimally invasive surgical procedures potentially increasing demand for micro guide catheters. Due to this, diagnosis and treatment of critical issues are emphasized to resolve using such techniques. This increases the importance of micro guide catheters. Therefore, this factor will govern the forecasted period, inflating the micro guide catheter market size.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The growing healthcare industry in North America will likely fuel the micro guide catheter market growth. The region will also provide a wider landscape for the leading micro guide catheter companies.
Emerging economies in the Asia-Pacific region will likely invest more in medical infrastructure, fueling the micro guide catheter market size. Technological developments in Europe help the region contribute to the better future of the industry’s competitive landscape.
Forecast CAGRs from 2024 to 2034
Countries | Forecasted CAGR |
---|---|
The United Kingdom | 5.2% |
Japan | 6% |
China | 6.4% |
India | 6.8% |
The United States of America | 6.9% |
With the growing technological infrastructure, the United Kingdom will help leading micro-guide catheter manufacturers innovate. The healthcare sector will likely use cutting-edge manufacturing practices for medical instruments.
The precision and accuracy of micro guide catheters will likely spur, driving their demand in the competitive landscape. This factor elevates the micro guide catheter market size in the United Kingdom at a moderate CAGR of 5.2%.
Japan’s micro guide catheter market growth is set to advance moderately at 6%. With the investments of large-scale organizations, the healthcare infrastructure in Japan will likely spur. Also, governmental support for these developments will accelerate the progress.
These advancements create various prospects for micro guide catheter use. As a result, the diversity of these instruments spikes, driving their demand with the enlargement in the micro guide catheter market size.
Due to the rapid rate of urbanization, the population in the country will likely face various lifestyle changes. The increased speed of life will increase pressure on an individual, which might induce more cardiovascular issues.
The growing demand for convenience food will also add to the driving force. This will fuel the landscape’s attractiveness. These factors will enhance the micro guide catheter market size in China, which will likely register a CAGR of 6.4%.
The micro guide catheter market growth in India will likely occur at 6.8% through 2034. The rising general awareness about cardiovascular diseases and the growing attention to the healthcare department in India will generate better prospects.
The government has increased healthcare expenditure, especially after COVID-19, which will likely increase in the forecasted period. This generates prospects for leading micro guide catheter companies.
The rising prevalence of chronic cardiovascular diseases is spurring in the United States. The country registers the highest number of patients affected due to heart-related disorders.
The advanced technological infrastructure helps leading micro guide catheter companies innovate and develop cutting-edge practices. These factors generate demand for interventional cardiology, spurring the need for micro-guide catheters. Therefore, the United States will be the largest industry, promising the fastest micro guide catheter market size enlargement at a CAGR of 6.9%.
Over-the-wire and cardiovascular intervention segments vastly govern the said sector. With the rising demand for accurate and less invasive treatments, these segments are gaining traction.
Category | Product type- Over-the-Wire |
---|---|
Industry Share in 2024 | 56.8% |
Segment Drivers |
|
Category | By Application- Cardiovascular Interventions |
---|---|
Industry Share in 2024 | 41.6% |
Segment Drivers |
|
With the help of various key industry expansion modes, including collaborations, partnerships, mergers, and acquisitions, businesses can gain a significant edge in the competitive landscape.
Leading micro guide catheter companies use these tactics to gain more space in the ecosystem. Strategies for new entrants to gain market share include developing innovation expertise, which will differentiate the product portfolio.
Strong tie-ups with suppliers and distributors will help them achieve a sustainable competitive edge. This collective ecosystem fuels the micro guide catheter market size.
Recent Industrial Developments
Attributes | Details |
---|---|
Estimated Size in 2024 | US$ 4.32 billion |
Projected Valuation in 2034 | US$ 8.02 billion |
Value-based CAGR 2024 to 2034 | 6.4% |
Forecast Period | 2024 to 2034 |
Historical Data Available for | 2019 to 2023 |
Analysis in- | Value in US$ billion |
Key Regions Covered |
North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; The Middle East and Africa |
Key Segments Covered |
Product, Application, End User, Region |
Key Countries Profiled |
The United States, Canada, Brazil, Mexico, Germany, The United Kingdom, France, Spain, Italy, Poland, Russia, Czech Republic, Romania, India, Bangladesh, Australia, New Zealand, China, Japan, South Korea, GCC Countries, South Africa, Israel |
Key Companies Profiled |
LuMend Corporation; Terumo Europe N.V.; Covidien AG; ASAHI INTECC Company Limited; Lake Region Manufacturing Inc.; Boston Scientific Corporation; Volcano Corporation; Micro Therapeutics Inc. |
The market is segmented as over-the-wire and flow-directed micro guide catheters.
The study on micro guide catheters by application include cardiovascular, neurovascular, and other applications.
Analysis of micro guide catheter sales in hospitals/clinics and ambulatory surgical centres.
Demand for micro guide catheters is studies in key countries across North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia and the Middle East and Africa
The micro guide catheter industry will progress at a CAGR of 6.4% through 2034.
The micro guide catheter ecosystem will reach US$ 8.02 billion by 2034.
The micro guide catheter landscape will reach US$ 4.32 billion in 2024.
The over-the-wire will hold 56.8% of the sector’s share in 2024.
The cardiovascular interventions will secure 41.6% of the competitive space in 2024.
1. Executive Summary
2. Industry Introduction, including Taxonomy and Market Definition
3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
5. Pricing Analysis
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
6.1. Product
6.2. Application
6.3. End User
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product
7.1. Over-The-Wire
7.2. Flow-Directed
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application
8.1. Cardiovascular
8.2. Neurovascular
8.3. Others
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
9.1. Hospitals/Clinics
9.2. Ambulatory Surgical Centres
10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
10.1. North America
10.2. Latin America
10.3. Western Europe
10.4. South Asia
10.5. East Asia
10.6. Eastern Europe
10.7. Middle East & Africa
11. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
12. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
13. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
14. South Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
15. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
16. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
17. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
18. Sales Forecast 2024 to 2034 by Product, Application, and End User for 30 Countries
19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
20. Company Profile
20.1. LUMEND INC
20.2. Terumo Europe NV
20.3. Covidien
20.4. Asahi Intecc Co Ltd
20.5. Lake Region Manufacturing Inc.
20.6. Boston Scientific Corporation
20.7. Volcano Corporation
20.8. Micro Therapeutics Inc.
Healthcare
June 2023
REP-GB-12575
220 pages
Explore Healthcare Insights
View Reports